Figure S2. High glucose and AGEs equally upregulated the expression of CD147. Brain microvascular endothelial cells (BMECs) were isolated and cultured, followed by immunoblot analysis for CD147 and actin as internal control. The densitometric quantification results are presented. Data expressed as mean ± SD and analyzed by two-way ANOVA. *P < 0.05 compared with non-diabetes saline-treated group, #P < 0.05 compared with non-diabetes rt-PA-treated group. (TIF 122 kb
Figure S3. Cytokine priming preserves cell viability and enhances chemokine and angiogenic proteins ...
Figure S3. Characterization of human brain-derived microvascular endothelial cells and fibroblasts d...
Figure S2. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S1. Diabetes upregulates serum levels of MMPs in rats. (A) Concentration of serum MMP-9 prote...
Figure S2. Isolation and separation of CD140b-positive ASCs by FACS sorting. Representative flow cyt...
Animal numbers used in each experimental assessment. Totally, four groups of mice were used in each ...
Showing the experimental design. Diabetes was induced in C57BL/6 male mice after daily intraperitone...
Figure S2. Surface marker dynamics during HSPC differentiation. a Schematic view of biphasic insulin...
Figure S1. Ins2Akita mice had markedly higher blood glucose levels. Blood glucose concentration (mg/...
Plasma levels of fractalkine and selective inflammatory cytokines were measured in 23 type-2 diabeti...
Figure S1. Human ECFCs and MSCs characterization. ECFCs derived from cord-blood present a typical co...
Figure S1. Characterization of GFP-BMSCs in vitro. (A, B, C) Representative images of CD44 biomarker...
Characterization of surface markers on M0, M1-, and M2-polarized macrophages derived from peripheral...
<i>Objectives:</i> Although intensive therapy for type 2 diabetes (T2D) prevents microvascular compl...
Figure S1. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S3. Cytokine priming preserves cell viability and enhances chemokine and angiogenic proteins ...
Figure S3. Characterization of human brain-derived microvascular endothelial cells and fibroblasts d...
Figure S2. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S1. Diabetes upregulates serum levels of MMPs in rats. (A) Concentration of serum MMP-9 prote...
Figure S2. Isolation and separation of CD140b-positive ASCs by FACS sorting. Representative flow cyt...
Animal numbers used in each experimental assessment. Totally, four groups of mice were used in each ...
Showing the experimental design. Diabetes was induced in C57BL/6 male mice after daily intraperitone...
Figure S2. Surface marker dynamics during HSPC differentiation. a Schematic view of biphasic insulin...
Figure S1. Ins2Akita mice had markedly higher blood glucose levels. Blood glucose concentration (mg/...
Plasma levels of fractalkine and selective inflammatory cytokines were measured in 23 type-2 diabeti...
Figure S1. Human ECFCs and MSCs characterization. ECFCs derived from cord-blood present a typical co...
Figure S1. Characterization of GFP-BMSCs in vitro. (A, B, C) Representative images of CD44 biomarker...
Characterization of surface markers on M0, M1-, and M2-polarized macrophages derived from peripheral...
<i>Objectives:</i> Although intensive therapy for type 2 diabetes (T2D) prevents microvascular compl...
Figure S1. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S3. Cytokine priming preserves cell viability and enhances chemokine and angiogenic proteins ...
Figure S3. Characterization of human brain-derived microvascular endothelial cells and fibroblasts d...
Figure S2. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...